M

MAIA Biotechnology, Inc.

24 employees

MAIA Biotechnology is an immuno-oncology company that focuses on developing first-in-class drugs with novel mechanisms.

Basic info

Industry

biotechnology research

Sectors

Pharmaceutical
Biotechnology
Immunotherapy
Telomere Targeting
Targeted Therapy
Research
Immmuno-Oncology
Small Molecule
Oncology
Drug development

Date founded

2018

Funding rounds raised

Total raised

$8M

from 2 investors over 2 rounds

M

MAIA Biotechnology, Inc. raised $8M on May 19, 2021

Investors: Checkmate Capital Group, LLC. and SSIF Broker

FAQ